Showing results (1-10 of 4) with videos related to
Sort By:
Pageof 1
Journal of Medical Economics|May 24, 2017
Cost-effectiveness of omalizumab add-on to standard-of-care therapy in patients with uncontrolled severe allergic asthma in a Brazilian healthcare settingCibele Suzuki, Nilceia Lopes da Silva, Praveen Kumar, et al.The Journal of Asthma : Official Journal of the Association for the Care of Asthma|April 27, 2016
Cost of severe asthma in Brazil-systematic reviewRoberto Stirbulov, Nilceia Lopes da Silva, Sarah Cristina Oliveira Machado Maia, et al.Health and Quality of Life Outcomes|August 7, 2015
Differences in utility scores obtained through Brazilian and UK value sets: a cross-sectional studyMaíra Libertad Soligo Takemoto, Nilceia Lopes da Silva, Ana Carolina Padula Ribeiro-Pereira, et al.BMC Health Services Research|March 25, 2016
Cost analysis of multiple sclerosis in Brazil: a cross-sectional multicenter studyNilceia Lopes da Silva, Maira L S Takemoto, Alfredo Damasceno, et al.Pageof 1